Meta facebook tracking pixel

Health care disparities occur when a person’s individual characteristics or circumstances—such as race, ethnicity, sexuality, gender identity, age or health insurance status—impact their access to health care or the quality of that care. These disparities can lead to cancer being diagnosed at a later stage, when it is harder to treat.

There has been increased attention on health care disparities, and many health-related organizations are focusing on ways to improve access to care and the quality of care. Medical institutions should abide by non-discriminatory policies, which can be posted on their website or within the care setting. Additionally, the healthcare delivery system is strengthened by the increased creativity and talent of a more diverse workforce. Administrators can promote or hire people with diverse viewpoints into positions of responsibility.

Organizations can also promote the concept of “cultural humility.” Cultural humility is the ability to remain open to another person’s identity. Cultural background, beliefs, values and traditions can impact how people make decisions about their health care. Being culturally humble involves reflection by the organization as a whole (and its health care providers) about their deep-rooted assumptions and being receptive to change.

It also involves recognizing power imbalances. For example, a patient may believe that they must accept health care recommendations without question. Health care providers should encourage patients and their families to discuss and collaborate on decisions regarding their health care.

Cultural humility also values institutional accountability. This means making sure the best options for care are available to everyone. Hospitals, public health administrations, insurance providers and others can take responsibility for differences in care and strive to reach health care equity.

Browse by Diagnosis

Browse by Topic

Thumbnail of the PDF version of Health Care Disparities and Cancer

Download a PDF(412 KB) of this publication.

This booklet is supported by GlaxoSmithKline.

Last updated Wednesday, February 12, 2025

The information presented in this publication is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.